PanOptix 目前预估已在全球完成超过 400 万枚植入。其卓越的视觉结局与患者满意度获得广泛认可。PanOptix 亦于 2021 年荣获美国第 50 届 Prix Galien “最佳医疗技术”大奖。 Clareon 平台代表了爱尔康在人工晶体材料方面的最新创新，提供具有高屈光可预测性、零闪辉材料、极低表面雾感并减少边缘炫光的解决方案，为外科医生带来信心，为患者带来持久清晰。以此为基础的 ...

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...

PanOptix delivers outstanding patient satisfaction and freedom from glasses; Vivity has a proven exceptionally low rate of ...

随着全球人口老龄化进程加速，白内障手术治疗已从单纯复明逐步转向追求更高质量的视觉体验。据行业数据显示，全球人工晶体（IOL）植入技术在临床应用中不断取得新进展，为患者术后视觉质量的提升提供了更多可能性。近日，在人工晶体领域深耕三十余年的爱尔康对外披露，其人工晶体全球植入量已突破1.75亿枚。其中，老视矫正 ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof ® IQ Vivity ® and Clareon ® Vivity ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been implanted worldwide.9,+ ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...